Export

EN
FR
Cryoprecipitate (native)
Essential medicine status
General description

Medicine type
Biological agent
EML status history
First added in 2023 (TRS 1049) for Haemophilia A
Changed in 2023 (TRS 1049) for Von Willebrand disease
Changed in 2023 (TRS 1049) for Obstetric haemorrhage
Therapeutic equivalent for
cryoprecipitate (pathogen-reduced) for Haemophilia A
cryoprecipitate (pathogen-reduced) for Coagulation defects, purpura or other haemorrhagic or related conditions, unspecified
cryoprecipitate (pathogen-reduced) for Von Willebrand disease
cryoprecipitate (pathogen-reduced) for Obstetric haemorrhage, unspecified
Wikipedia
Cryoprecipitate (native)